153 related articles for article (PubMed ID: 26065862)
1. Neonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy.
Bergin SP; Thaden JT; Ericson JE; Cross H; Messina J; Clark RH; Fowler VG; Benjamin DK; Hornik CP; Smith PB;
Pediatr Infect Dis J; 2015 Sep; 34(9):933-6. PubMed ID: 26065862
[TBL] [Abstract][Full Text] [Related]
2. No survival benefit with empirical vancomycin therapy for coagulase-negative staphylococcal bloodstream infections in infants.
Ericson JE; Thaden J; Cross HR; Clark RH; Fowler VG; Benjamin DK; Cohen-Wolkowiez M; Hornik CP; Smith PB;
Pediatr Infect Dis J; 2015 Apr; 34(4):371-5. PubMed ID: 25760564
[TBL] [Abstract][Full Text] [Related]
3. Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit.
Cordero L; Rau R; Taylor D; Ayers LW
Am J Infect Control; 2004 Jun; 32(4):189-95. PubMed ID: 15175611
[TBL] [Abstract][Full Text] [Related]
4. Survival Benefit of Empirical Therapy for Staphylococcus aureus Bloodstream Infections in Infants.
Thaden JT; Ericson JE; Cross H; Bergin SP; Messina JA; Fowler VG; Benjamin DK; Clark RH; Hornik CP; Smith PB;
Pediatr Infect Dis J; 2015 Nov; 34(11):1175-9. PubMed ID: 26222060
[TBL] [Abstract][Full Text] [Related]
5. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
[TBL] [Abstract][Full Text] [Related]
6. Increasing incidence and antimicrobial resistance in Escherichia coli bloodstream infections: a multinational population-based cohort study.
MacKinnon MC; McEwen SA; Pearl DL; Lyytikäinen O; Jacobsson G; Collignon P; Gregson DB; Valiquette L; Laupland KB
Antimicrob Resist Infect Control; 2021 Sep; 10(1):131. PubMed ID: 34488891
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic Susceptibility of Escherichia coli Among Infants Admitted to Neonatal Intensive Care Units Across the US From 2009 to 2017.
Flannery DD; Akinboyo IC; Mukhopadhyay S; Tribble AC; Song L; Chen F; Li Y; Gerber JS; Puopolo KM
JAMA Pediatr; 2021 Feb; 175(2):168-175. PubMed ID: 33165599
[TBL] [Abstract][Full Text] [Related]
8. Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy.
Tumbarello M; Sali M; Trecarichi EM; Leone F; Rossi M; Fiori B; De Pascale G; D'Inzeo T; Sanguinetti M; Fadda G; Cauda R; Spanu T
Antimicrob Agents Chemother; 2008 Sep; 52(9):3244-52. PubMed ID: 18591273
[TBL] [Abstract][Full Text] [Related]
9. Neonatal bloodstream infections in a Ghanaian Tertiary Hospital: Are the current antibiotic recommendations adequate?
Labi AK; Obeng-Nkrumah N; Bjerrum S; Enweronu-Laryea C; Newman MJ
BMC Infect Dis; 2016 Oct; 16(1):598. PubMed ID: 27776490
[TBL] [Abstract][Full Text] [Related]
10. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
[TBL] [Abstract][Full Text] [Related]
11. A ten-year review of ESBL and non-ESBL Escherichia coli bloodstream infections among children at a tertiary referral hospital in South Africa.
Malande OO; Nuttall J; Pillay V; Bamford C; Eley B
PLoS One; 2019; 14(9):e0222675. PubMed ID: 31550295
[TBL] [Abstract][Full Text] [Related]
12. Bloodstream infections in a neonatal intensive-care unit: 12 years' experience with an antibiotic control program.
Cordero L; Sananes M; Ayers LW
Infect Control Hosp Epidemiol; 1999 Apr; 20(4):242-6. PubMed ID: 10219874
[TBL] [Abstract][Full Text] [Related]
13. Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study.
Mehl A; Åsvold BO; Kümmel A; Lydersen S; Paulsen J; Haugan I; Solligård E; Damås JK; Harthug S; Edna TH
BMC Infect Dis; 2017 Feb; 17(1):116. PubMed ID: 28148226
[TBL] [Abstract][Full Text] [Related]
14. Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.
Pascual V; Alonso N; Simó M; Ortiz G; Garcia MC; Xercavins M; Rivera A; Morera MA; Miró E; Espejo E; Navarro F; Gurguí M; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E
Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1997-2003. PubMed ID: 27549108
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007.
Al-Hasan MN; Lahr BD; Eckel-Passow JE; Baddour LM
J Antimicrob Chemother; 2009 Jul; 64(1):169-74. PubMed ID: 19435736
[TBL] [Abstract][Full Text] [Related]
17. Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis.
Bizzarro MJ; Dembry LM; Baltimore RS; Gallagher PG
Pediatrics; 2008 Apr; 121(4):689-96. PubMed ID: 18381532
[TBL] [Abstract][Full Text] [Related]
18. Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
Martelius T; Jalava J; Kärki T; Möttönen T; Ollgren J; Lyytikäinen O;
Infect Dis (Lond); 2016; 48(3):229-34. PubMed ID: 26577519
[TBL] [Abstract][Full Text] [Related]
19. Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study.
Thom KA; Schweizer ML; Osih RB; McGregor JC; Furuno JP; Perencevich EN; Harris AD
BMC Infect Dis; 2008 Sep; 8():116. PubMed ID: 18793400
[TBL] [Abstract][Full Text] [Related]
20. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
